Avecho Biotechnology Ord Shs V.AVE

Primary Symbol: AVEFF

Healthcare

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

OTCPK:AVEFF - Post by User

Avecho Biotechnology Ord Shs

Bullboard Posts

Post by CJ14on Jul 14, 2017 3:17pm

151 Views

Post# 26470769

Next week will see some action!

Next week will be exciting for AVE. Former BNN host Mark Bunting has a daily note that is followed by a large group. Bunting indicated on Wednesday that Canacord has initiated coverage on this company. He also indicated that he will be talking more about this company in his digest which comes out just before the markets open on Monday. Today Bunting mentioned in his daily note that the Digest on Monday will focus on the 12 Top Ideas for Q3. I believe that AVE will be one of them by reading between the lines. If so, buckle up starting on Monday morning. Cheers all! Pete

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!